Toggle navigation
Home
Pulse
Channels
CME
Profile
Home
Pulse
Channels
CME
Profile
Kamran Ahmed
Moffitt
Vice Chair of Clinical Research and Section Chief of Breast Radiation Oncology at Moffitt Cancer Center
51
Talks
278.4k
Listens
Talks
NRG/RTOG 1005 Trial: Key Takeaways
June 12, 2026
Share
NRG/RTOG 1005 Trial: Key Takeaways
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=12507
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
NRG/RTOG 1005 Trial: Cosmetic Outcomes
June 12, 2026
Share
NRG/RTOG 1005 Trial: Cosmetic Outcomes
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=12506
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
NRG/RTOG 1005 Trial: Adverse Events
June 12, 2026
Share
NRG/RTOG 1005 Trial: Adverse Events
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=12505
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
NRG/RTOG 1005 Trial: Disease Recurrence Events & Survival
June 12, 2026
Share
NRG/RTOG 1005 Trial: Disease Recurrence Events & Survival
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=12504
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
NRG/RTOG 1005 Trial: Ipsilateral Breast Recurrence
June 12, 2026
Share
NRG/RTOG 1005 Trial: Ipsilateral Breast Recurrence
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=12502
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
NRG/RTOG 1005 Trial: Patient Characteristics
June 12, 2026
Share
NRG/RTOG 1005 Trial: Patient Characteristics
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=12501
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
NRG/RTOG 1005 Trial: Procedures
June 12, 2026
Share
NRG/RTOG 1005 Trial: Procedures
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=12499
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
NRG/RTOG 1005 Trial: Study Design
June 12, 2026
Share
NRG/RTOG 1005 Trial: Study Design
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=12497
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
NRG/RTOG 1005 Trial: Key Objective
June 12, 2026
Share
NRG/RTOG 1005 Trial: Key Objective
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=12495
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
NRG/RTOG 1005 Trial: Overview
June 12, 2026
Share
NRG/RTOG 1005 Trial: Overview
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=12493
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Secondary Analysis of RxPONDER: Key Takeaways
May 8, 2026
Share
Secondary Analysis of RxPONDER: Key Takeaways
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11154
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Secondary Analysis of RxPONDER: Factors Influencing Cognitive Outcomes
May 8, 2026
Share
Secondary Analysis of RxPONDER: Factors Influencing Cognitive Outcomes
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11153
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Secondary Analysis of RxPONDER: Clinically Meaningful Change
May 8, 2026
Share
Secondary Analysis of RxPONDER: Clinically Meaningful Change
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11152
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Secondary Analysis of RxPONDER: Comparisons of Mean Cognitive Function Score
May 8, 2026
Share
Secondary Analysis of RxPONDER: Comparisons of Mean Cognitive Function Score
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11151
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Secondary Analysis of RxPONDER: Chemoendocrine Therapy (CET) vs Endocrine Therapy (ET)
May 8, 2026
Share
Secondary Analysis of RxPONDER: Chemoendocrine Therapy (CET) vs Endocrine Therapy (ET)
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11150
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Secondary Analysis of RxPONDER: Participant Baseline Characteristics
May 8, 2026
Share
Secondary Analysis of RxPONDER: Participant Baseline Characteristics
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11149
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Secondary Analysis of RxPONDER: PROMIS Questionnaire
May 8, 2026
Share
Secondary Analysis of RxPONDER: PROMIS Questionnaire
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11148
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Secondary Analysis of RxPONDER: Study Design
May 8, 2026
Share
Secondary Analysis of RxPONDER: Study Design
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11146
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Secondary Analysis of RxPONDER: Cancer-Related Cognitive Impairment
May 8, 2026
Share
Secondary Analysis of RxPONDER: Cancer-Related Cognitive Impairment
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11145
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Secondary Analysis of RxPONDER: Overview
May 8, 2026
Share
Secondary Analysis of RxPONDER: Overview
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11144
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
WISDOM Trial: Key Takeaways
April 9, 2026
Share
WISDOM Trial: Key Takeaways
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11041
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
WISDOM Trial: Limitations
April 9, 2026
Share
WISDOM Trial: Limitations
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11040
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
WISDOM Trial: Risk Model Validity
April 9, 2026
Share
WISDOM Trial: Risk Model Validity
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11039
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
WISDOM Trial: Mammogram Rates
April 9, 2026
Share
WISDOM Trial: Mammogram Rates
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11038
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
WISDOM Trial: Biopsy Rates
April 9, 2026
Share
WISDOM Trial: Biopsy Rates
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11037
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
WISDOM Trial: Non-Inferiority Results
April 9, 2026
Share
WISDOM Trial: Non-Inferiority Results
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11036
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
WISDOM Trial: Risk-Based Screening Strategy
April 9, 2026
Share
WISDOM Trial: Risk-Based Screening Strategy
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11035
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
WISDOM Trial: Study Design & Participants
April 9, 2026
Share
WISDOM Trial: Study Design & Participants
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11034
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
WISDOM Trial: Primary Objective
April 9, 2026
Share
WISDOM Trial: Primary Objective
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11033
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Rethinking Breast Cancer Screening
April 9, 2026
Share
Rethinking Breast Cancer Screening
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=11032
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
HypoG-01 Trial: Key Takeaways
March 13, 2026
Share
HypoG-01 Trial: Key Takeaways
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10904
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
HypoG-01 Trial: Safety Profile
March 13, 2026
Share
HypoG-01 Trial: Safety Profile
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10903
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
HypoG-01 Trial: Oncologic Outcomes
March 13, 2026
Share
HypoG-01 Trial: Oncologic Outcomes
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10901
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
HypoG-01 Trial: Primary Outcome Results
March 13, 2026
Share
HypoG-01 Trial: Primary Outcome Results
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10900
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
HypoG-01 Trial: Primary Endpoint Definition
March 13, 2026
Share
HypoG-01 Trial: Primary Endpoint Definition
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10899
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
HypoG-01 Trial: Treatment Arms
March 13, 2026
Share
HypoG-01 Trial: Treatment Arms
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10898
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
HypoG-01 Trial: Study Design
March 13, 2026
Share
HypoG-01 Trial: Study Design
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10897
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
HypoG-01 Trial: Study Objective
March 13, 2026
Share
HypoG-01 Trial: Study Objective
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10896
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
HypoG-01 Trial: Clinical Background
March 13, 2026
Share
HypoG-01 Trial: Clinical Background
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10895
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
HypoG-01 Trial: Overview
March 13, 2026
Share
HypoG-01 Trial: Overview
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10894
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
OPBC-07/microNAC: Clinical Implications
February 24, 2026
Share
OPBC-07/microNAC: Clinical Implications
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10736
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
OPBC-07/microNAC: Residual Nodal Disease
February 24, 2026
Share
OPBC-07/microNAC: Residual Nodal Disease
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10735
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
OPBC-07/microNAC: Key Findings
February 24, 2026
Share
OPBC-07/microNAC: Key Findings
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10734
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
OPBC-07/microNAC: Comparative Outcomes
February 24, 2026
Share
OPBC-07/microNAC: Comparative Outcomes
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10731
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
OPBC-07/microNAC: Study Profile
February 24, 2026
Share
OPBC-07/microNAC: Study Profile
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10730
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
OPBC-07/microNAC: Methods
February 24, 2026
Share
OPBC-07/microNAC: Methods
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10729
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
OPBC-07/microNAC: Primary Objective
February 24, 2026
Share
OPBC-07/microNAC: Primary Objective
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10728
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
OPBC-07/microNAC: Modern Clinical Practice
February 24, 2026
Share
OPBC-07/microNAC: Modern Clinical Practice
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10727
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
OPBC-07/microNAC: Standard Treatment and the Shift Toward Surgical De-Escalation
February 24, 2026
Share
OPBC-07/microNAC: Standard Treatment and the Shift Toward Surgical De-Escalation
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10726
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
OPBC-07/microNAC: Study Overview
February 24, 2026
Share
OPBC-07/microNAC: Study Overview
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10725
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Supremo Trial
January 15, 2026
Share
Supremo Trial
https://www.medspoke.co/channel_playlist?object_id=795&tap_id=10252
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Why are you reporting this TALK?
